The alkaloidal fraction of Alstonia scholaris leaves shows anti-inflammatory and analgesic bioactivity in vivo. A phytochemical study on this fraction led to the isolation of two novel alkaloids, scholarisine I and (±)-scholarisine II. Their structures were elucidated on the basis of spectroscopic methods, and a possible biogenesis is proposed. (±)-Scholarisine II selectively inhibited the inducible COX-2 rather than COX-1, and also markedly inhibited 5-LOX, comparable to positive controls.
Introduction
The leaves of Alstonia scholaris, named dengtaiye by local people, have been historically used in "dai" ethnopharmacy to treat chronic respiratory diseases in the Yunnan province of the People's Republic of China [1] . The aqueous extract of the leaves, developed as a commercially available traditional Chinese medicine used to release tracheitis and cold symptoms, has also been prescribed in hospitals and sold over the counter in drug stores [2] . This established clinical efficiency stimulated us to investigate the bioactive compounds from this plant. The traditional and clinical uses are related to anti-inflammatory and analgesic actions. In vivo anti-inflammatory and analgesic assays of a fractionated extract indicated that the alkaloid fraction contained the bioactive component. At doses of 10, 20, 40 and 80 mg per kg, the alkaloid fraction reduced the writhing reflex in mice by 48.4, 40.1, 36.6 and 49.5 %, respectively, comparable to aspirin at 200 mg/kg (57.2 %). At doses of 50 and 100 mg/kg, the alkaloid fraction decreased xyleneinduced ear edema in mice by 46.0 and 41.2 %, comparable to aspirin at 200 mg/kg (45.7 %). This promising bioactivity led us to initiate a phytochemical and pharmacological investigation on the A. scholaris extract. As part of this endeavor, more than 40 alkaloids, including three monoterpenoid indole alkaloids with rearranged skeletons and further elaboration, were isolated [3, 4] and subjected to anti-inflammatory evaluation against COX-1, COX-2 and 5-LOX in vitro. In 0932-0776 / 10 / 0900-1164 $ 06.00 c 2010 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com this paper, we describe the isolation, structure elucidation and anti-inflammatory effect of two novel quinoline alkaloids from A. scholaris (Fig. 1) .
Results and Discussion
Compound 1 was deduced to have a molecular formula of C 17 H 13 NO 2 as evidenced by 1 (12)), 7.76 (1H, t, J = 7.5, H-C(10)), 7.61 (1H, t, J = 7.5, H-C(11)) suggested that 1 was a unsubstituted A-ring quinoline-type alkaloid [5] . 13 C NMR data and HMBC correlations of scholarisine I and II a . 13 C) spectroscopic data of 1 and 2 were recorded in CDCl 3 on Bruker AM-400 and DRX-500 instruments, respectively; δ in ppm, J in Hz.
Fig. 2. Key HMBC and ROESY correlations of scholarisines I (1) and II (2).
Besides the carboxylic methyl ester and double bond, another 10 double bond equivalents required the presence of another benzene ring, which was fused to the quinoline ring at C-6 and C-7. The signal at δ (H) = 8.07 (s) showed HMBC cross peaks to both δ (C) = 153.4 (s, C(5)) and a terminal double bond carbon at δ (C) = 134.8 (d, C(19)), which placed a vinyl group at the ortho-position. This suggestion could be further supported by NOE correlations between H-C(21) and both H-C(5) and H-C(19). In the HMBC spectrum, correlations from the singlet signal at δ (H) = 8.04 to δ (C) = 171.4 (s) and 134.8 (d, C(19)) positioned the carboxylic methyl ester at C(16). Thus, 1 was elucidated as shown in Fig. 1 , and named scholarisine I. Its numbering system is according to that of monoterpenoid indole alkaloids. All of the 1 H and 13 C NMR signals of 1 were assigned by HSQC, HMBC, and ROESY experiments (Table 1, Fig. 2 ).
Compound 2 was found to possess a molecular formula of C 17 H 15 NO 3 Fig. 2) .
A small specific rotation value ([α] 26 D = −1.1) was detected for compound 2, caused by the only chiral carbon (C-19), which prompted us to determine its configuration by Mosher's method [6] . However, when (R/S)-Mosher's esters were obtained, 1 H NMR spectra for both esters exhibited the presence of a pair of isomers. The integrals of the peaks in the 1 H NMR spectrum suggested the presence of a pair of enantiomers with proportions of 10 : 9 for compound 2. A chiral column, Chiralcel OD-H (5 µm, 10 × 250 mm 2 ), was used for further purification, eluting with petroleum ether-isopropanol (9 : 1). Finally, Analysis of compound 1 indicated that the structure, consisting of a quinoline skeleton and a 4-methylhexenyl carboxylic methyl ester group (Fig. 3) , most likely derives from degradation and rearrangement of a monoterpenoid indole alkaloid. Similar to the biosynthesis of quinine [7] , the cleavage of the N(1)-C(2), N(4)-C(5) and N(4)-C(21) bonds in the indole heterocyclic ring of strictamine could generate a "dialdehyde" at C(5) and C(21) together with an amide group (Fig. 3) . Subsequently, C(2/7) and C(14/15) might be cleaved, leading to the loss of the fragment -C(2)-C(3)-N(4)-C(14)-. Nucleophilic attack of C(6) on C(21) and of -NH 2 on C(5) would form a unique quinoline skeleton [8] . Finally, the intermediate might be reduced, and with elimination of two molecules of H 2 O would yield 1. Compound 2 could be formed by addition of H 2 O across the C(18/19) double bond of 1.
A direct route to the quinoline ring system, such as for dictamnine and skimmianine in Dictamnus albus and Skimmia japonica (Rutaceae), is possible through the combination of anthranilic acid and acetate/malonate, and an extension of this process also can account for the origin of the acridine ring system [9] . On the other hand, some remarkable quinoline alkaloids, such as quinine [10] and camptothecin [11] , well known for their antimalarial and anticancer properties, have been established to arise by rearrangement of monoterpenoid indole alkaloids. Although few compounds of the latter type have been reported, they seem to show a high probability of having drug-like activity compared with other natural products.
The development of inflammatory diseases may be accompanied by increased production of leukotrienes and prostaglandins from arachidonic acid. COX-1 and COX-2 are responsible for the production of prostaglandins and LOX for leukotrienes. Inhibition of cyclooxygenase by non-steroidal anti-inflammatory drugs and selective COX-2 inhibitors reduces the levels of prostaglandins, resulting in a reduction in pain and inflammation. However, this inhibition can cause alternative processing of arachidonic acid via the 5-lipoxygenase (5-LOX) pathway, resulting in increased production of pro-inflammatory and gastrotoxic leukotrienes. The dual inhibitors of COX and 5-LOX decrease the production of both leukotrienes and prostaglandins, and as such, they should theoretically display enhanced anti-inflammatory effects and decreased cardiovascular side effects caused by some selective COX-2 inhibitors, such as rofecoxib Table 2 . COX-1 and -2, and 5-LOX inhibitory effects of compounds 1 and 2 a . and valdecoxib. Thus, the development of new skeletons which show dual inhibition of COX and 5-LOX currently attracts much attention [12] . COX-1 and -2, and 5-LOX inhibitory effects for compounds 1 and 2 were assayed. Compound 1 showed inhibition to both COX-1 and -2 isoforms. To our interest, compound 2 selectively inhibited the inducible COX-2 to a much greater extent than COX-1, and also markedly inhibited 5-LOX, comparable to positive controls ( Table 2) . Because of the limited amount of the two alkaloids available, they were tested at a single concentration, 100 µ M
Experimental Section

General
Optical rotations were measured with a Horiba SEAP-300 spectropolarimeter. UV spectra were recorded on a Shimadzu double-beam 210A spectrophotometer. IR (KBr) spectra were obtained on a Bio-Rac. FTS-135 infrared spectrophotometer. 1 H, 13 C and 2D NMR spectra were recorded on AM-400 and DRX-500 MHz NMR spectrometers with TMS as internal standard. MS data were obtained on API Qstar Pulsar I and Finnigan LCQ Advantage instruments. Silica gel (200 -300 mesh) for column chromatography and GF 254 for TLC were obtained from Qingdao Marine Chemical Factory, Qingdao, People's Republic of China, and sprayed with Dragdorff's reagent. C18 silica gel (20 -45 µm) was bought from Fuji Chemical Ltd. HPLC was performed using Waters 600 pumps coupled with a Waters 2996 photodiode array detector and a Waters fraction collector II. All enzymes (COX-1 or COX-2 and 5-LOX) were purchased from SigmaAldrich Company Ltd.
Plant material
The leaves of A. scholaris (L.) R. Br. were collected in April 2006 in Simao of Yunnan Province, People's Republic of China, and identified by Dr. C. X. Zeng, Key Laboratory of Biodiversity and Biogeography, Kunming Institute of Botany, The Chinese Academy of Sciences. A voucher specimen (Luo20060407) has been deposited in the herbarium of Kunming Institute of Botany, The Chinese Academy of Sciences (KUN).
Extraction and isolation
The dried and powdered leaves of A. scholaris (10 kg) were extracted with EtOH (60 L × 3) under reflux conditions, and the solvent evaporated in vacuo. The residue was dissolved in 1 % aqueous HCl, and the solution was subsequently basified using dilute aqueous ammonia to pH = 9 -10. The basic solution was partitioned with EtOAc, affording an aqueous phase and an EtOAc/organic phase. The EtOAc fraction (105 g) was collected, redissolved in MeOH, and subjected to column chromatography on silica gel, eluting with CHCl 3 -Me 2 CO (from CHCl 3 to CHCl 3 -Me 2 CO (1 : 1)) to afford five fractions (I -V). Fraction II (4 g) was further chromatographed on RP-18 silica gel eluting with 70 % aqueous methanol to afford subfraction II-1. Subfraction II-1 was separated by silica gel once again using petroleum etherMe 2 CO (from 9 : 1 to 4 : 1) to give compounds 1 (6 mg) and 2 (4 mg).
Assay for COX-1 and -2, and 5-LOX inhibitory effects
The anti-inflammatory activity was tested according to the literature with minor modifications [13] . Briefly, the reaction system was incubated for 5 min at 25 • C before sequential addition of the buffer, heme, test compounds, and COX-1 or COX-2 into the system followed by mixing with TMPD and arachidonic acid, and soft agitation for several seconds. The absorbance value was recorded at a wavelength of 590 nm after another 15 min of incubation at 25 • C. The performance of the assay was checked using SC-560 and NS-398 as positive controls, which caused inhibition of COX-1 (61.3 %) and COX-2 (97.1 %), respectively. Different from the method described above, the reaction system was added to assay buffer with 5-LOX in the presence of the colorimetric substrate and test compounds and then incubated for a period of 5 min at 25 • C. After the completion of the reaction, the chromogen was added, and the plate was shaken softly for a few seconds. A further 5 min incubation was performed at 25 • C. The inhibitory effect against 5-LOX was determined by measuring the absorbance at a wavelength of 500 nm. The performance of the assay was checked using zileuton as a positive control, which inhibited 5-LOX activity by 83.1 %. 1 H NMR (500 MHz, CDCl 3 ) and 13 C NMR (125 MHz, CDCl 3 ) spectroscopic data: see Table 1 .
